12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
During Tuesday's pre-market session, several health care stocks experienced significant movement. LianBio, TransCode Therapeutics, MyMD Pharmaceuticals, Vivos Therapeutics, Organovo Holdings, and Revelation Biosciences saw increases in their stock prices. Conversely, LumiraDx, INVO Bioscience, Oncology Institute, Citius Pharma, SAB Biotherapeutics, and TC BioPharm experienced decreases.
October 24, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LianBio's stock increased by 79.8% to $2.5 during Tuesday's pre-market session.
The significant increase in LianBio's stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
TransCode Therapeutics' shares increased by 33.85% to $0.41.
The substantial increase in TransCode Therapeutics' share price suggests positive investor sentiment, potentially leading to further short-term increases.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Citius Pharma's stock declined by 11.73% to $0.59.
The substantial decrease in Citius Pharma's stock price suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
LumiraDx's shares decreased by 35.6% to $0.18 during Tuesday's pre-market session.
The significant decrease in LumiraDx's share price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100